ANIK – Anika Therapeutics Inc.
ANIK — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
2.79
Margin Of Safety %
-43
Put/Call OI Ratio
0.77
EPS Next Q Diff
-0.11
EPS Last/This Y
0.94
EPS This/Next Y
-0.1
Price
21.48
Target Price
21
Analyst Recom
1
Performance Q
41.48
Upside
-144.1%
Beta
0.2
Ticker: ANIK
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-07-13 | ANIK | 15.73 | 0.26 | 0.00 | 131 |
| 2026-07-14 | ANIK | 15.53 | 0.26 | 1.00 | 132 |
| 2026-07-15 | ANIK | 15.87 | 0.26 | 1.00 | 134 |
| 2026-07-16 | ANIK | 15.82 | 0.26 | 1.00 | 134 |
| 2026-07-17 | ANIK | 15.23 | 0.27 | 0.00 | 136 |
| 2026-07-20 | ANIK | 15.02 | 0.12 | 6.00 | 116 |
| 2026-07-21 | ANIK | 15.14 | 0.17 | 999.99 | 124 |
| 2026-07-22 | ANIK | 15.17 | 0.24 | 0.09 | 131 |
| 2026-07-23 | ANIK | 14.66 | 0.22 | 0.00 | 143 |
| 2026-07-24 | ANIK | 14.93 | 0.22 | 999.99 | 145 |
| 2026-07-27 | ANIK | 15.07 | 0.32 | 0.50 | 157 |
| 2026-07-28 | ANIK | 15.2 | 0.33 | 999.99 | 163 |
| 2026-07-29 | ANIK | 16.23 | 0.37 | 0.00 | 168 |
| 2026-07-30 | ANIK | 18.06 | 0.37 | 0.50 | 168 |
| 2026-07-31 | ANIK | 19.25 | 0.33 | 0.00 | 188 |
| 2026-08-03 | ANIK | 20.74 | 0.33 | 0.91 | 188 |
| 2026-08-04 | ANIK | 19.59 | 0.33 | 34.00 | 201 |
| 2026-08-05 | ANIK | 19.2 | 0.53 | 2.26 | 232 |
| 2026-08-07 | ANIK | 21.48 | 0.77 | 0.00 | 327 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-07-13 | ANIK | 15.74 | 123.1 | - | 0.41 |
| 2026-07-14 | ANIK | 15.52 | 123.1 | - | 0.41 |
| 2026-07-15 | ANIK | 15.87 | 123.1 | - | 0.41 |
| 2026-07-16 | ANIK | 15.84 | 123.1 | - | 0.41 |
| 2026-07-17 | ANIK | 15.27 | 123.1 | - | 0.41 |
| 2026-07-20 | ANIK | 15.07 | 123.1 | - | 0.41 |
| 2026-07-21 | ANIK | 15.16 | 123.1 | - | 0.41 |
| 2026-07-22 | ANIK | 15.02 | 123.1 | - | 0.41 |
| 2026-07-23 | ANIK | 14.65 | 123.1 | - | 0.41 |
| 2026-07-24 | ANIK | 14.93 | 123.1 | - | 0.41 |
| 2026-07-27 | ANIK | 15.01 | 123.1 | - | 0.41 |
| 2026-07-28 | ANIK | 15.17 | 123.1 | - | 0.41 |
| 2026-07-29 | ANIK | 16.13 | 123.1 | - | 0.41 |
| 2026-07-30 | ANIK | 18.09 | 123.1 | - | 0.41 |
| 2026-07-31 | ANIK | 19.27 | -25.0 | - | 0.41 |
| 2026-08-03 | ANIK | 20.74 | -25.0 | - | 0.41 |
| 2026-08-04 | ANIK | 20.74 | -25.0 | - | 0.41 |
| 2026-08-05 | ANIK | 19.18 | -25.0 | - | 0.41 |
| 2026-08-06 | ANIK | 20.16 | -25.0 | - | 0.41 |
| 2026-08-07 | ANIK | 21.48 | 325.0 | - | 1.05 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-07-13 | ANIK | 2.09 | 0.33 | 3.34 |
| 2026-07-14 | ANIK | 2.09 | 0.33 | 3.34 |
| 2026-07-15 | ANIK | 2.09 | 0.33 | 3.34 |
| 2026-07-16 | ANIK | 2.09 | 0.33 | 3.34 |
| 2026-07-17 | ANIK | 2.09 | 0.33 | 3.34 |
| 2026-07-20 | ANIK | 2.09 | 0.24 | 3.34 |
| 2026-07-21 | ANIK | 2.09 | 0.24 | 3.34 |
| 2026-07-22 | ANIK | 2.09 | 0.24 | 3.34 |
| 2026-07-23 | ANIK | 2.09 | 0.24 | 3.34 |
| 2026-07-24 | ANIK | 2.09 | 0.24 | 3.34 |
| 2026-07-27 | ANIK | 2.09 | -7.16 | 2.80 |
| 2026-07-28 | ANIK | 2.09 | -7.16 | 2.80 |
| 2026-07-29 | ANIK | 2.09 | -7.16 | 2.80 |
| 2026-07-30 | ANIK | 2.09 | -7.16 | 2.80 |
| 2026-07-31 | ANIK | 2.09 | -7.16 | 2.80 |
| 2026-08-03 | ANIK | 2.08 | -6.50 | 2.79 |
| 2026-08-04 | ANIK | 2.08 | -6.50 | 2.79 |
| 2026-08-05 | ANIK | 2.33 | -6.50 | 2.79 |
| 2026-08-06 | ANIK | 2.33 | -6.50 | 2.79 |
| 2026-08-07 | ANIK | 2.33 | -6.50 | 2.79 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
0.3
Avg. EPS Est. Current Quarter
0.17
Avg. EPS Est. Next Quarter
0.19
Insider Transactions
2.33
Institutional Transactions
-6.5
Beta
0.2
Average Sales Estimate Current Quarter
29
Average Sales Estimate Next Quarter
30
Fair Value
12.34
Quality Score
44
Growth Score
34
Sentiment Score
91
Actual DrawDown %
53.1
Max Drawdown 5-Year %
-82
Target Price
21
P/E
Forward P/E
29.14
PEG
0.25
P/S
2.38
P/B
2.09
P/Free Cash Flow
511.9
EPS
-0.27
Average EPS Est. Cur. Y
1.05
EPS Next Y. (Est.)
0.95
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-3.14
Relative Volume
2.28
Return on Equity vs Sector %
-30.1
Return on Equity vs Industry %
-9.6
EPS 1 7Days Diff
0.6
EPS 1 30Days Diff
0.64
EBIT Estimation
◆
ANIK
Healthcare
$21.42
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
75.4
Range 1M
97.7%
Sup Dist
8.6%
Momentum Growth
Ride accelerating trends
WATCH
EPS Yr
381.8%
EPS NY
38.7%
52W%
98.8%
Long-Term Value
Quality companies, undervalued
WEAK
🟡 HOLD
+14.5% upside
Upside
+14.5%
Quality
44
MoS
-43%
ANIK — P/E HistoricalBiotechnology
Anika Therapeutics Inc.Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees: 235
Anika Therapeutics, Inc., a joint preservation company, focuses on early intervention orthopedics in the United States, Europe, and internationally. The company offers osteoarthritis (OA) pain management products and services, such as Monovisc and Orthovisc, which are single- and multi-injection, HA viscosupplement products indicated for pain relief from OA conditions, as well as Cingal, a non-opioid, single-injection OA pain management product; regenerative solutions, including an HA-based scaffold with bone and tendon fixation components and arthroscopic delivery instruments; Hyalofast, a resorbable scaffold used for single stage cartilage regeneration; and Tactoset injectable bone substitute, an HA-enhanced injectable bone repair therapy designed to treat insufficiency fractures and augment hardware fixation. It also provides Integrity, an HA-based scaffold with bone and tendon fixation components and arthroscopic delivery instruments; non-orthopedic products, including Hyvisc, a high molecular weight injectable HA veterinary product for the treatment of joint dysfunction in horses due to non-infectious synovitis associated with equine OA; Hyalobarrier, an anti-adhesion barrier indicated for use after abdominal-pelvic surgeries; and ophthalmic products; and Anikavisc and Nuvisc high molecular weight HA products. The company was founded in 1983 and is headquartered in Bedford, Massachusetts.
ANIK
Latest News
—
Caricamento notizie per ANIK…
stock quote shares ANIK – Anika Therapeutics Inc. Stock Price stock today
news today ANIK – Anika Therapeutics Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch ANIK – Anika Therapeutics Inc. yahoo finance google finance
stock history ANIK – Anika Therapeutics Inc. invest stock market
stock prices ANIK premarket after hours
ticker ANIK fair value insiders trading